Nanopath

Cambridge, MA · Founded 2019 · Privately Held (backing)

Developer of a molecular diagnostic platform designed to enable point-of-care disease diagnosis. Nanopath is based in Cambridge, MA and was founded in 2019. It was valued at $32 million at its early-stage round in Aug 2022, the last priced event on record. It has raised $16.4 million across 2 recorded rounds; the latest was a $5.3 million debt round in Jan 2025.

PMV mark · valuation
$32.0M
Oct 2026
Priced at
its early-stage round
Aug 2022
Total raised
$16.4M
Last round
Debt
Jan 2025

Who backs Nanopath?

17 investors
InvestorType
Alumni VenturesVenture capital
Creative Destruction LabOther
US National Science FoundationOther
Service Provider CapitalVenture capital
National Institutes of HealthOther
NorwestVenture capital
The EngineOther
MassVenturesOther
SV Health InvestorsVenture capital
GingerBread CapitalFamily office
+ 7 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Nanopath investors

17 investors are on record for Nanopath, including Alumni Ventures, Creative Destruction Lab, US National Science Foundation and Service Provider Capital. By type, the record holds 4 venture capital firms and 1 family office. The debt round in Jan 2025 drew 5 investors.

Free account
More of Nanopath with a free account
  • ·The complete investor list: 17 names
  • ·Watch Nanopath: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 17 firms already write checks for companies like Nanopath. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View